发明名称 RECOMBINANT ALPHAVIRUS-BASED VECTOR WITH REDUCED INHIBITION OF CELLULAR MACRO-MOLECULAR SYNTHESIS
摘要 <P>PROBLEM TO BE SOLVED: To provide recombinant vectors with selected desirable phenotypes for use in a variety of applications, including for example, gene therapy and recombinant protein production, and further provide other related advantages. <P>SOLUTION: This isolated nucleic acid molecules comprise an altered alphavirus nonstructural protein gene which, when operably incorporated into a recombinant alphavirus particle, increases the time required to reach 50% inhibition of host-cell directed macromolecular synthesis following expression in mammalian cells, as compared to a wild-type alphavirus. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013090630(A) 申请公布日期 2013.05.16
申请号 JP20120262618 申请日期 2012.11.30
申请人 NOVARTIS VACCINES & DIAGNOSTICS INC;WASHINGTON UNIV 发明人 DUBENSKY THOMAS W JR;POLO JOHN M;BELLI BARBARA A;SCHLESINGER SONDRA;DRYGA SERGEY A;FROLOV ILYA
分类号 C12N15/09;A61K31/7088;A61K35/76;A61K39/00;A61K48/00;A61P43/00;C07K14/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N7/01;C12N7/04;C12N15/19;C12N15/24;C12N15/79;C12N15/86;C12P21/02 主分类号 C12N15/09
代理机构 代理人
主权项
地址